| Trial ID: | L0075 |
| Source ID: | NCT02681991
|
| Associated Drug: |
Renamezin Capsule
|
| Title: |
Phase Ⅳ Clinical Trial to Evaluate of Renamezin in Patients With Chronic Renal Failure.
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Renal Failure
|
| Interventions: |
DRUG: Renamezin capsule
|
| Outcome Measures: |
Primary: change from baseline of Indoxyl sulfate at 8weeks, 0, 8weeks |
|
| Sponsor/Collaborators: |
Sponsor: Daewon Pharmaceutical Co., Ltd.
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
110
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2016-01
|
| Completion Date: |
2016-09
|
| Results First Posted: |
|
| Last Update Posted: |
2017-07-06
|
| Locations: |
Gangnam Sevrance Hospital of Yonsei University, Seoul, Gangnam-gu, 06273, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT02681991
|
